We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,672 hedge funds and large institutions have $321B invested in Johnson & Johnson in 2022 Q2 according to their latest regulatory filings, with 131 funds opening new positions, 1,619 increasing their positions, 1,536 reducing their positions, and 88 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more first-time investments, than exits

New positions opened: 131 | Existing positions closed: 88

45% more funds holding in top 10

Funds holding in top 10: 532773 (+241)

33% more call options, than puts

Call options by funds: $3.35B | Put options by funds: $2.52B

5% more repeat investments, than reductions

Existing positions increased: 1,619 | Existing positions reduced: 1,536

0.04% less ownership

Funds ownership: 69.15%69.11% (-0.04%)

0% less funds holding

Funds holding: 3,6773,672 (-5)

12% less capital invested

Capital invested by funds: $365B → $321B (-$44.1B)

Holders
3,672
Holders Change
-5
Holders Change %
-0.14%
% of All Funds
61.85%
Holding in Top 10
773
Holding in Top 10 Change
+241
Holding in Top 10 Change %
+45.3%
% of All Funds
13.02%
New
131
Increased
1,619
Reduced
1,536
Closed
88
Calls
$3.35B
Puts
$2.52B
Net Calls
+$833M
Net Calls Change
-$135M
Name Holding Trade Value Shares
Change
Change in
Stake
BF
301
BOK Financial
Oklahoma
$66.6M +$1.52M +8,514 +2%
NYLIM
302
New York Life Investment Management
New York
$66.4M +$66.7M +374,205 New
RCAMU
303
Rothschild & Co Asset Management US
Connecticut
$66.4M -$1.5M -8,404 -2%
CIP
304
Cornerstone Investment Partners
Georgia
$66.4M -$8.26M -46,333 -11%
MOACM
305
Mutual of America Capital Management
New York
$65.7M +$1.24M +6,934 +2%
FDCDDQ
306
Federation des caisses Desjardins du Quebec
Quebec, Canada
$64.5M -$2.46M -13,817 -4%
Vontobel Holding
307
Vontobel Holding
Switzerland
$64.5M +$4.86M +27,282 +8%
SLAM
308
Swiss Life Asset Management
$64.4M -$4.9M -27,475 -7%
LWCFA
309
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$64.2M +$11.4K +64 +0%
DLA
310
Douglas Lane & Associates
New York
$63.3M +$1.36M +7,638 +2%
AIMCA
311
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$62.9M -$19.2M -107,863 -23%
WIC
312
Willis Investment Counsel
Georgia
$62.8M -$2.21M -12,379 -3%
EWA
313
EP Wealth Advisors
California
$62.6M +$1.71M +9,578 +3%
UB
314
UMB Bank
Missouri
$62.3M -$378K -2,124 -0.6%
TPSF
315
Texas Permanent School Fund
Texas
$61.7M +$1.09M +6,101 +2%
Citadel Advisors
316
Citadel Advisors
Florida
$61.6M -$130M -731,210 -68%
MCM
317
MAI Capital Management
Ohio
$60.4M +$2.48M +13,932 +4%
HP
318
Hikari Power
Japan
$60.3M
KCM
319
Kornitzer Capital Management
Kansas
$60M -$1.19M -6,658 -2%
NIMI
320
Natixis Investment Managers International
France
$60M -$5.07M -28,470 -8%
TIA
321
Tandem Investment Advisors
South Carolina
$59.1M +$1.1M +6,156 +2%
DCM
322
Donaldson Capital Management
Indiana
$58.7M +$1.3M +7,307 +2%
ORIO
323
Old Republic International (ORI)
Illinois
$58.5M
Berkshire Hathaway
324
Berkshire Hathaway
Nebraska
$58.1M
IMPI
325
Ilmarinen Mutual Pension Insurance
Finland
$58M

JNJ Hedge Fund Activity: Q2 2022 in Review

3,672 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2022, worth a combined $321B — down 12% from $365B a quarter earlier.

Buyers outnumbered sellers: 131 funds opened new JNJ positions and 88 closed out — a net gain of 43 holders — while 1,619 added to existing stakes and 1,536 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.12B. The largest seller was Arrowstreet Capital, cutting an estimated $1.18B.

  • 3,672 institutional investors held Johnson & Johnson (JNJ) as of Q2 2022, down from 3,677 in Q1 2022.
  • Funds reported $321B of Johnson & Johnson stock for Q2 2022, down 12% quarter-over-quarter.
  • 131 funds opened new Johnson & Johnson positions in Q2 2022 and 88 closed out, a net change of +43 holders.
  • The largest Johnson & Johnson buyer in Q2 2022 was Morgan Stanley, an estimated $2.12B added.
  • The largest Johnson & Johnson seller in Q2 2022 was Arrowstreet Capital, an estimated $1.18B sold.

Based on aggregated 13F filings for Q2 2022.